Literature DB >> 34741281

Delayed body development with reduced triglycerides levels in leptin transgenic pigs.

Yubo Qing1,2,3, Muhammad Ameen Jamal1,2,4, Dejia Shi1,2,4, Sumei Zhao1,2,4, Kaixiang Xu1,2,4, Deling Jiao1,2,4, Heng Zhao1,2,3, Honghui Li1,2,4, Baoyu Jia1,2,3, Haizhen Wang3, Hong-Ye Zhao1,2,5, Hong-Jiang Wei6,7,8,9.   

Abstract

Leptin is a well-known adipokine that plays critical role in adiposity. To further investigate the role of leptin in adiposity, we utilized leptin overexpressing transgenic pigs and evaluated the effect of leptin on growth and development, fat deposition, and lipid metabolism at tissue and cell level. Leptin transgenic pigs were produced and divided into two groups: elevated leptin expression (leptin ( +)) and normal leptin expression group (control). Results indicated that leptin ( +) pigs had elevated leptin protein and mRNA expression levels and exhibited sluggish growth and development followed by decreased subcutaneous fat thickness, low serum triglycerides, saturated, unsaturated fatty acids and high cholesterol esters (p < 0.05). There were differences in the lipid metabolism related genes at different fat depots, including upregulation of PPARγ, AGPAT6, PLIN2, HSL and ATGL in subcutaneous, PPARγ in perirenal, and FAT/CD36 and PLIN2 in mesenteric adipose tissues and downregulation of AGPAT6 and ATGL in perirenal and AGPAT6 in mesenteric adipose tissues (p < 0.05). Additionally, in-vitro cultured leptin ( +) preadipocytes exhibited upregulation of PPARγ, FAT/CD36, ACACA, AGPAT, PLIN2, ATGL and HSL as compared to control (p < 0.05). These findings suggested that homeostasis imbalance in lipolysis and lipogenesis at adipose tissue and adipocytes levels led to low subcutaneous fat depots in leptin overexpression pigs. These pigs can act as model for obesity and related metabolic disorder.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Body development; Leptin transgenic pigs; Lipid metabolism genes; Serum triglycerides

Mesh:

Substances:

Year:  2021        PMID: 34741281     DOI: 10.1007/s11248-021-00288-1

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  5 in total

1.  Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes.

Authors:  Suresh Ambati; Hye-Kyeong Kim; Jeong-Yeh Yang; Ji Lin; Mary Anne Della-Fera; Clifton A Baile
Journal:  Biochem Pharmacol       Date:  2006-10-17       Impact factor: 5.858

2.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Authors:  S B Heymsfield; A S Greenberg; K Fujioka; R M Dixon; R Kushner; T Hunt; J A Lubina; J Patane; B Self; P Hunt; M McCamish
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

3.  Serum leptin level is a regulator of bone mass.

Authors:  F Elefteriou; S Takeda; K Ebihara; J Magre; N Patano; C Ae Kim; Y Ogawa; X Liu; S M Ware; W J Craigen; J J Robert; C Vinson; K Nakao; J Capeau; G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

4.  Perilipin2 plays a positive role in adipocytes during lipolysis by escaping proteasomal degradation.

Authors:  Yu Takahashi; Akihiro Shinoda; Haruhiko Kamada; Makoto Shimizu; Jun Inoue; Ryuichiro Sato
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

5.  Effects of fat-to-sugar ratio in excess dietary energy on lipid abnormalities: a 7-month prospective feeding study in adult cynomolgus monkeys.

Authors:  Ke-Wei Wang; Bai-Quan Xiao; Bi-Hai Li; Yi-Yan Liu; Zhi-Yuan Wei; Jun-Hua Rao; Jian-Huan Chen
Journal:  Lipids Health Dis       Date:  2019-01-05       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.